TD SYNNEX (SNX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for April 2, 2025, with proxy materials available online and voting accessible via internet, phone, or mail.
Fiscal year 2024 highlights: $58.5B revenue (+2% y/y), $80.1B non-GAAP gross billings (+4% y/y), $7.95 diluted EPS (+19% y/y), $1.2B cash from operations, ~$750M returned to shareholders.
CEO transition completed with Patrick Zammit appointed as President and CEO; new director Ting Herh added to the Board.
Voting matters and shareholder proposals
Election of ten directors for one-year terms.
Advisory vote on executive compensation (Say-on-Pay).
Ratification of KPMG LLP as independent auditors.
Amendments to the Charter: eliminate supermajority voting, remove obsolete provisions, limit liability for certain officers.
Proposal to create a stockholder right to call a special meeting (25% ownership threshold).
Stockholder proposal to allow 10% ownership threshold for calling special meetings, which the Board recommends voting against.
Board of directors and corporate governance
Board comprises ten nominees, majority independent, with diverse backgrounds (four women, three from underrepresented communities, one military veteran).
Board committees: Audit, Compensation, and Nominating & Corporate Governance, all with independent members.
Board and committees met regularly; all directors attended at least 75% of meetings.
Director compensation includes cash retainers and equity grants, with increases effective after the 2025 Annual Meeting.
Latest events from TD SYNNEX
- Key votes include director elections, say-on-pay, auditor ratification, and a charter amendment.SNX
Proxy Filing13 Feb 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and ESG progress.SNX
Proxy Filing13 Feb 2026 - Board seeks approval for director elections, executive pay, auditor ratification, and expanded shareholder rights.SNX
Proxy Filing3 Feb 2026 - Q2 delivered 3% gross billings growth, margin gains, and strong shareholder returns.SNX
Q2 20243 Feb 2026 - Q3 non-GAAP gross billings up 9% to $20.3B; revenue $14.7B; Q4 outlook strong.SNX
Q3 202420 Jan 2026 - Q4 revenue rose 10% with strong cash flow, robust capital returns, and a higher dividend.SNX
Q4 202410 Jan 2026 - Record Q4 and FY results with 15% billings growth, 24% EPS gain, and strong FY26 outlook.SNX
Q4 20258 Jan 2026 - Gross billings up 8%, revenue up 4%, EPS within guidance, and dividend raised 10%.SNX
Q1 202520 Dec 2025 - Proxy covers director elections, governance reforms, and strong financial and ESG performance.SNX
Proxy Filing1 Dec 2025